Advanced drug design and development: a medicinal chemistry approach
Gespeichert in:
Format: | Elektronisch E-Book |
---|---|
Sprache: | English |
Veröffentlicht: |
New York
Ellis Horwood
1994
|
Schriftenreihe: | Ellis Horwood series in pharmaceutical technology
|
Schlagworte: | |
Online-Zugang: | FAW01 FAW02 Volltext |
Beschreibung: | Includes bibliographical references and index Book Cover; Half-Title; Title; Copyright; Dedication; Table of Contents; Preface; 1 Introduction; 2 Structure-activity studies and drug design with antagonists at histamine H2 receptors; 3 Acetylcholine, GABA and excitatory amino acid receptors in neurodegenerative disorders; 4 Physicochemical properties and drug action: alternative QSAR methods; 5 Biotransformation of drugs in man: characterization and prediction; 6 The role of computational chemistry in molecular modelling; 7 The importance of labelling of bioactive compounds in the development of new drugs Reporting the rapidly growing field of rational drug design, this work is composed from a selected, topical range of chapters written by specialists in each field |
Beschreibung: | 1 Online-Ressource (141 pages) |
ISBN: | 0133367932 0203999886 9780203999882 |
Internformat
MARC
LEADER | 00000nmm a2200000zc 4500 | ||
---|---|---|---|
001 | BV043075629 | ||
003 | DE-604 | ||
005 | 00000000000000.0 | ||
007 | cr|uuu---uuuuu | ||
008 | 151126s1994 |||| o||u| ||||||eng d | ||
020 | |a 0133367932 |9 0-13-336793-2 | ||
020 | |a 0203999886 |c electronic bk. |9 0-203-99988-6 | ||
020 | |a 9780203999882 |c electronic bk. |9 978-0-203-99988-2 | ||
035 | |a (OCoLC)50705169 | ||
035 | |a (DE-599)BVBBV043075629 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
049 | |a DE-1046 |a DE-1047 | ||
082 | 0 | |a 615/.19 |2 20 | |
245 | 1 | 0 | |a Advanced drug design and development |b a medicinal chemistry approach |c edited by P.N. Kourounakis and E. Rekka |
264 | 1 | |a New York |b Ellis Horwood |c 1994 | |
300 | |a 1 Online-Ressource (141 pages) | ||
336 | |b txt |2 rdacontent | ||
337 | |b c |2 rdamedia | ||
338 | |b cr |2 rdacarrier | ||
490 | 0 | |a Ellis Horwood series in pharmaceutical technology | |
500 | |a Includes bibliographical references and index | ||
500 | |a Book Cover; Half-Title; Title; Copyright; Dedication; Table of Contents; Preface; 1 Introduction; 2 Structure-activity studies and drug design with antagonists at histamine H2 receptors; 3 Acetylcholine, GABA and excitatory amino acid receptors in neurodegenerative disorders; 4 Physicochemical properties and drug action: alternative QSAR methods; 5 Biotransformation of drugs in man: characterization and prediction; 6 The role of computational chemistry in molecular modelling; 7 The importance of labelling of bioactive compounds in the development of new drugs | ||
500 | |a Reporting the rapidly growing field of rational drug design, this work is composed from a selected, topical range of chapters written by specialists in each field | ||
650 | 7 | |a MEDICAL / Drug Guides |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
650 | 7 | |a MEDICAL / Pharmacy |2 bisacsh | |
650 | 7 | |a MEDICAL / Nursing / Pharmacology |2 bisacsh | |
650 | 4 | |a Drug Design / Congresses | |
650 | 4 | |a Structure-Activity Relationship / Congresses | |
650 | 4 | |a Chemistry, Pharmaceutical / Congresses | |
650 | 4 | |a Models, Molecular / Congresses | |
650 | 4 | |a Medizin | |
650 | 4 | |a Drugs |x Design | |
650 | 4 | |a Pharmaceutical chemistry |x Research |x Methodology | |
650 | 0 | 7 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
689 | 0 | 0 | |a Arzneimitteldesign |0 (DE-588)4278218-1 |D s |
689 | 0 | |8 1\p |5 DE-604 | |
689 | 1 | 0 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 1 | |8 2\p |5 DE-604 | |
700 | 1 | |a Kourounakis, P. N. |e Sonstige |4 oth | |
700 | 1 | |a Rekka, E. A. |e Sonstige |4 oth | |
856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230 |x Aggregator |3 Volltext |
912 | |a ZDB-4-EBA | ||
999 | |a oai:aleph.bib-bvb.de:BVB01-028499821 | ||
883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext |
Datensatz im Suchindex
_version_ | 1804175462924025856 |
---|---|
any_adam_object | |
building | Verbundindex |
bvnumber | BV043075629 |
collection | ZDB-4-EBA |
ctrlnum | (OCoLC)50705169 (DE-599)BVBBV043075629 |
dewey-full | 615/.19 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.19 |
dewey-search | 615/.19 |
dewey-sort | 3615 219 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Electronic eBook |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03422nmm a2200637zc 4500</leader><controlfield tag="001">BV043075629</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s1994 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0133367932</subfield><subfield code="9">0-13-336793-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0203999886</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">0-203-99988-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780203999882</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-0-203-99988-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50705169</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043075629</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.19</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Advanced drug design and development</subfield><subfield code="b">a medicinal chemistry approach</subfield><subfield code="c">edited by P.N. Kourounakis and E. Rekka</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York</subfield><subfield code="b">Ellis Horwood</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (141 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Ellis Horwood series in pharmaceutical technology</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Book Cover; Half-Title; Title; Copyright; Dedication; Table of Contents; Preface; 1 Introduction; 2 Structure-activity studies and drug design with antagonists at histamine H2 receptors; 3 Acetylcholine, GABA and excitatory amino acid receptors in neurodegenerative disorders; 4 Physicochemical properties and drug action: alternative QSAR methods; 5 Biotransformation of drugs in man: characterization and prediction; 6 The role of computational chemistry in molecular modelling; 7 The importance of labelling of bioactive compounds in the development of new drugs</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Reporting the rapidly growing field of rational drug design, this work is composed from a selected, topical range of chapters written by specialists in each field</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Drug Guides</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacy</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Nursing / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Design / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Structure-Activity Relationship / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemistry, Pharmaceutical / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Molecular / Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Design</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical chemistry</subfield><subfield code="x">Research</subfield><subfield code="x">Methodology</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Arzneimitteldesign</subfield><subfield code="0">(DE-588)4278218-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kourounakis, P. N.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rekka, E. A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028499821</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift gnd-content |
genre_facet | Konferenzschrift |
id | DE-604.BV043075629 |
illustrated | Not Illustrated |
indexdate | 2024-07-10T07:16:41Z |
institution | BVB |
isbn | 0133367932 0203999886 9780203999882 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028499821 |
oclc_num | 50705169 |
open_access_boolean | |
owner | DE-1046 DE-1047 |
owner_facet | DE-1046 DE-1047 |
physical | 1 Online-Ressource (141 pages) |
psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
publishDate | 1994 |
publishDateSearch | 1994 |
publishDateSort | 1994 |
publisher | Ellis Horwood |
record_format | marc |
series2 | Ellis Horwood series in pharmaceutical technology |
spelling | Advanced drug design and development a medicinal chemistry approach edited by P.N. Kourounakis and E. Rekka New York Ellis Horwood 1994 1 Online-Ressource (141 pages) txt rdacontent c rdamedia cr rdacarrier Ellis Horwood series in pharmaceutical technology Includes bibliographical references and index Book Cover; Half-Title; Title; Copyright; Dedication; Table of Contents; Preface; 1 Introduction; 2 Structure-activity studies and drug design with antagonists at histamine H2 receptors; 3 Acetylcholine, GABA and excitatory amino acid receptors in neurodegenerative disorders; 4 Physicochemical properties and drug action: alternative QSAR methods; 5 Biotransformation of drugs in man: characterization and prediction; 6 The role of computational chemistry in molecular modelling; 7 The importance of labelling of bioactive compounds in the development of new drugs Reporting the rapidly growing field of rational drug design, this work is composed from a selected, topical range of chapters written by specialists in each field MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Design / Congresses Structure-Activity Relationship / Congresses Chemistry, Pharmaceutical / Congresses Models, Molecular / Congresses Medizin Drugs Design Pharmaceutical chemistry Research Methodology Arzneimitteldesign (DE-588)4278218-1 gnd rswk-swf Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Arzneimitteldesign (DE-588)4278218-1 s 1\p DE-604 Arzneimittelentwicklung (DE-588)4143176-5 s 2\p DE-604 Kourounakis, P. N. Sonstige oth Rekka, E. A. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230 Aggregator Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
spellingShingle | Advanced drug design and development a medicinal chemistry approach MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Design / Congresses Structure-Activity Relationship / Congresses Chemistry, Pharmaceutical / Congresses Models, Molecular / Congresses Medizin Drugs Design Pharmaceutical chemistry Research Methodology Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
subject_GND | (DE-588)4278218-1 (DE-588)4143176-5 (DE-588)1071861417 |
title | Advanced drug design and development a medicinal chemistry approach |
title_auth | Advanced drug design and development a medicinal chemistry approach |
title_exact_search | Advanced drug design and development a medicinal chemistry approach |
title_full | Advanced drug design and development a medicinal chemistry approach edited by P.N. Kourounakis and E. Rekka |
title_fullStr | Advanced drug design and development a medicinal chemistry approach edited by P.N. Kourounakis and E. Rekka |
title_full_unstemmed | Advanced drug design and development a medicinal chemistry approach edited by P.N. Kourounakis and E. Rekka |
title_short | Advanced drug design and development |
title_sort | advanced drug design and development a medicinal chemistry approach |
title_sub | a medicinal chemistry approach |
topic | MEDICAL / Drug Guides bisacsh MEDICAL / Pharmacology bisacsh MEDICAL / Pharmacy bisacsh MEDICAL / Nursing / Pharmacology bisacsh Drug Design / Congresses Structure-Activity Relationship / Congresses Chemistry, Pharmaceutical / Congresses Models, Molecular / Congresses Medizin Drugs Design Pharmaceutical chemistry Research Methodology Arzneimitteldesign (DE-588)4278218-1 gnd Arzneimittelentwicklung (DE-588)4143176-5 gnd |
topic_facet | MEDICAL / Drug Guides MEDICAL / Pharmacology MEDICAL / Pharmacy MEDICAL / Nursing / Pharmacology Drug Design / Congresses Structure-Activity Relationship / Congresses Chemistry, Pharmaceutical / Congresses Models, Molecular / Congresses Medizin Drugs Design Pharmaceutical chemistry Research Methodology Arzneimitteldesign Arzneimittelentwicklung Konferenzschrift |
url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=136230 |
work_keys_str_mv | AT kourounakispn advanceddrugdesignanddevelopmentamedicinalchemistryapproach AT rekkaea advanceddrugdesignanddevelopmentamedicinalchemistryapproach |